rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Ora H. Pescovitz

Director

Company insider

Files Form 4 as: Director, MBX Biosciences; Director, Life Technologies.

In numbers

Trades disclosed
24
Buys
3
Sells
0
Bought
$76K
Sold
$0
Companies
2
Companies where not an officer
2
First trade
2 May 2011
Last trade
4 Jun 2026
Last filed
5 Jun 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
MBX MBX BiosciencesDirector · Biotechnology · last 4 Jun 20261 buy · 0 sells
Life TechnologiesDirector · last 3 Feb 20142 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
01Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
4 Jun 2026filed 5 Jun 2026MBX MBX Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—12,500 at $0.00filing
4 Jun 2026filed 5 Jun 2026MBX MBX Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—12,500 at $0.00filing
5 Jun 2025filed 6 Jun 2025MBX MBX Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—16,000 at $0.00filing
8 Apr 2025filed 10 Apr 2025MBX MBX BiosciencesBiotechnologySEC FORM 4 Bought$45K7,693 at $5.89filing
12 Sep 2024filed 13 Sep 2024MBX MBX Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—15,963 at $0.00filing
3 Feb 2014filed 4 Feb 2014Life TechnologiesSEC FORM 4 Code D$57K750 at $76.13filing
3 Feb 2014filed 4 Feb 2014Life TechnologiesSEC FORM 4 Code D$415K5,451 at $76.13filing
3 Jan 2014filed 7 Jan 2014Life TechnologiesSEC FORM 4 Code A—391 at $0.00filing
1 Oct 2013filed 2 Oct 2013Life TechnologiesSEC FORM 4 Code A—359 at $0.00filing
1 Jul 2013filed 2 Jul 2013Life TechnologiesSEC FORM 4 Code A—308 at $0.00filing
1 Apr 2013filed 3 Apr 2013Life TechnologiesSEC FORM 4 Code A—409 at $0.00filing
2 Jan 2013filed 2 Jan 2013Life TechnologiesSEC FORM 4 Code A—592 at $0.00filing
1 Oct 2012filed 1 Oct 2012Life TechnologiesSEC FORM 4 Code A$24K482 at $49.31filing
2 Jul 2012filed 2 Jul 2012Life TechnologiesSEC FORM 4 Code A—773 at $0.00filing
2 Apr 2012filed 21 Feb 2013Life TechnologiesSEC FORM 4 Code A—527 at $0.00filing
2 Apr 2012filed 4 Apr 2012Life TechnologiesSEC FORM 4 Code A—563 at $0.00filing
3 Jan 2012filed 4 Jan 2012Life TechnologiesSEC FORM 4 Code A—528 at $0.00filing
3 Oct 2011filed 4 Oct 2011Life TechnologiesSEC FORM 4 Code A—699 at $0.00filing
22 Aug 2011filed 24 Aug 2011Life TechnologiesSEC FORM 4 Bought$1,80850 at $36.16filing
22 Aug 2011filed 24 Aug 2011Life TechnologiesSEC FORM 4 Bought$7,232200 at $36.16filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Health Care1
Not placed2

Buys in green, sells in red, by the company’s sector.

Related people

Salomon AzoulayChief Medical Officer · Chief Medical Officer at MBX Biosciences, filing Form 4 there in the last year
Steven L. HoerterPresident and CEO · President and CEO at MBX Biosciences, filing Form 4 there in the last year
John W. SmitherDirector · Chief Financial Officer at MBX Biosciences, filing Form 4 there in the last year
Edward T. MathersDirector · Director at MBX Biosciences, filing Form 4 there in the last year
Tiba AynechiDirector · Director at MBX Biosciences, filing Form 4 there in the last year